These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7026903)

  • 1. Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia.
    Bradstock KF; Janossy G; Tidman N; Papageorgiou ES; Prentice HG; Willoughby M; Hoffbrand AV
    Leuk Res; 1981; 5(4-5):301-9. PubMed ID: 7026903
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of bone marrow lymphocytosis after induction treatment in common acute lymphoblastic leukemia. Marker analysis and significance.
    Ifrah N; Boucheix C; Marie JP; Innes J; Perrot JY; Rio B; Cadiou M; Zittoun R
    Cancer; 1986 Nov; 58(9):2018-22. PubMed ID: 3463396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of acute leukemia with lympho- and myeloblastic blast cell characteristics].
    Tupitsyn NN; Baryshnikov AIu; Makhonova LA; Peterson IS; Morozova LF
    Gematol Transfuziol; 1984 Aug; 29(8):49-54. PubMed ID: 6332760
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
    Greaves MF; Janossy G; Peto J; Kay H
    Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells.
    Greaves M; Delia D; Janossy G; Rapson N; Chessells J; Woods M; Prentice G
    Leuk Res; 1980; 4(1):15-32. PubMed ID: 6931953
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic cell markers in acute lymphoblastic leukemia in children].
    Grigor'iants LIa
    Eksp Onkol; 1987; 9(2):28-30. PubMed ID: 3495426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses.
    Thoene I; Kabisch H
    Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of antigens on acute lymphoblastic leukemias.
    Rodt H; Netzel B; Thiel E; Hoffmann-Fezer G; Thierfelder S
    Haematol Blood Transfus; 1979; 23():347-52. PubMed ID: 317475
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenotypic changes in acute lymphoblastic leukemia cells of the common type in diffusion chambers.
    Lau B; Jäger G; Thiel E; Pachmann K; Rodt H; Huhn D; Thierfelder S; Dörmer P
    Leuk Res; 1980; 4(6):561-9. PubMed ID: 6970862
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
    Borella L; Sen L; Casper JT
    J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of antihuman thymocyte serum with acute leukemic blasts.
    Mills B; Sen L; Borella L
    J Immunol; 1975 Oct; 115(4):1038-44. PubMed ID: 1100719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The T or B nature of neoplastic cells in lymphotic leukemia].
    Belpomme D; Dant Chev D; Du Rusquec E; Grandjon D; Huchet R; Pinon F; Pouillart P; Schwarzenberg L; Amiel JL; Mathé G
    Bull Cancer; 1974; 61(3):387-402. PubMed ID: 4618783
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
    Dorlhiac P; Genter G; Jamra M
    Sangre (Barc); 1981; 26(4):433-8. PubMed ID: 6974901
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and immunological correlates of leukemia cutis in childhood.
    Dunn NL; McWilliams NB; Mohanakumar T
    Cancer; 1982 Nov; 50(10):2049-51. PubMed ID: 6957256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cell surface markers in childhood acute lymphoblastic leukaemia.
    Kumar S; Carr TF; Evans DI; Morris-Jones P; Hann IM
    Clin Lab Haematol; 1979; 1(2):121-8. PubMed ID: 317037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempts at stimulation of immune response in acute lymphod leukaemia.
    Mathé G; Schwarzenberg L; Schneider M; Haya M; de Vassal F; Pouillart P; Amiel JL
    Proc R Soc Med; 1972 Mar; 65(3):266-70. PubMed ID: 5083315
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological rebound after cessation of long-term chemotherapy in acute lymphocytic leukaemia: changes in distribution of T and B cell populations in bone marrow and peripheral blood.
    Sen L; Borella L
    Br J Haematol; 1974 Jul; 27(3):477-87. PubMed ID: 4213175
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute lymphoblastic leukaemia cells in the diffusion chamber: change of surface phenotype during the culture period.
    Jäger G; Lau B; Pachmann K; Dörmer P
    Br J Haematol; 1982 Oct; 52(2):319-25. PubMed ID: 6751379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T- and B-lymphocytes and lymphoblasts in untreated acute lymphocytic leukemia.
    Borella L; Sen L
    Cancer; 1974 Sep; 34(3):646-51. PubMed ID: 4605204
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell differentiation antigens versus tumor-related antigens in childhood acute lymphoblastic leukemia (ALL). Clinical significance of leukemia markers.
    Borella L; Sen L; Dow LW; Casper JT
    Haematol Blood Transfus; 1977; 20():77-85. PubMed ID: 305404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.